Cargando…

GATA5 CpG island hypermethylation is an independent predictor for poor clinical outcome in renal cell carcinoma

Transcriptional inactivation and CpG island (CGI) methylation of GATA transcription factor family members GATA3 and GATA5 have been reported for a few types of human cancer. Whether high-density CGI methylation of GATA3 or GATA5 is associated with the clinical course of patients with renal cell canc...

Descripción completa

Detalles Bibliográficos
Autores principales:	PETERS, INGA, GEBAUER, KAI, DUBROWINSKAJA, NATALIA, ATSCHEKZEI, FARANAZ, KRAMER, MARIO W., HENNENLOTTER, JOERG, TEZVAL, HOSSEIN, ABBAS, MAHMOUD, SCHERER, RALPH, MERSEBURGER, AXEL S., STENZL, ARNULF, KUCZYK, MARKUS A., SERTH, JUERGEN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2014
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975988/ https://www.ncbi.nlm.nih.gov/pubmed/24549248 http://dx.doi.org/10.3892/or.2014.3030

Ejemplares similares

Tumor Specific Epigenetic Silencing of Corticotropin Releasing Hormone -Binding Protein in Renal Cell Carcinoma: Association of Hypermethylation and Metastasis
por: Tezval, Hossein, et al.
Publicado: (2016)

Neurofilament Heavy polypeptide CpG island methylation associates with prognosis of renal cell carcinoma and prediction of antivascular endothelial growth factor therapy response
por: Dubrowinskaja, Natalia, et al.
Publicado: (2014)

Decreased GATA5 mRNA expression associates with CpG island methylation and shortened recurrence-free survival in clear cell renal cell carcinoma
por: Peters, Inga, et al.
Publicado: (2014)

Hsa-mir-124-3 CpG island methylation is associated with advanced tumours and disease recurrence of patients with clear cell renal cell carcinoma
por: Gebauer, K, et al.
Publicado: (2013)

Reduced mrna expression level of corticotropin-releasing hormone-binding protein is associated with aggressive human kidney cancer
por: Tezval, Hossein, et al.
Publicado: (2013)

Age-, tumor-, and metastatic tissue-associated DNA hypermethylation of a T-box brain 1 locus in human kidney tissue
por: Serth, Jürgen, et al.
Publicado: (2020)

Fibronectin 1 mRNA expression correlates with advanced disease in renal cancer
por: Waalkes, Sandra, et al.
Publicado: (2010)

Galectin-1 and Galectin-3 mRNA expression in renal cell carcinoma
por: von Klot, Christoph-A, et al.
Publicado: (2014)

Identification of a Novel Renal Metastasis Associated CpG-Based DNA Methylation Signature (RMAMS)
por: Serth, Jürgen, et al.
Publicado: (2022)

CpG island hypermethylation go circular (RNA)
por: Dragomir, Mihnea P., et al.
Publicado: (2018)

DNA Methylation Biomarkers Predict Progression-Free and Overall Survival of Metastatic Renal Cell Cancer (mRCC) Treated with Antiangiogenic Therapies
por: Peters, Inga, et al.
Publicado: (2014)

DNA methylation of tumor associated calcium signal transducer 2 (TACSTD2) loci shows association with clinically aggressive renal cell cancers
por: Katzendorn, Olga, et al.
Publicado: (2021)

Aberrant CpG Islands Hypermethylation Profiles in Malignant Gliomas
por: Kim, Kwang Ryeol, et al.
Publicado: (2014)

DNA Methylation in INA, NHLH2, and THBS4 Is Associated with Metastatic Disease in Renal Cell Carcinoma
por: Katzendorn, Olga, et al.
Publicado: (2021)

Alteration of Cadherin 3 Expression and DNA Methylation in Association with Aggressive Renal Cell Carcinoma
por: Faraj Tabrizi, Pouriya, et al.
Publicado: (2023)

Genomic insights into cancer-associated aberrant CpG island hypermethylation
por: Sproul, Duncan, et al.
Publicado: (2013)

CpG Island Hypermethylation in Gastric Carcinoma and Its Premalignant Lesions
por: Kang, Gyeong Hoon
Publicado: (2012)

Frequent hypermethylation of orphan CpG islands with enhancer activity in cancer
por: Bae, Min Gyun, et al.
Publicado: (2016)

RASSF1A protein expression and correlation with clinicopathological parameters in renal cell carcinoma
por: Tezval, Hossein, et al.
Publicado: (2008)

Identifying hypermethylated CpG islands using a quantile regression model
por: Sun, Shuying, et al.
Publicado: (2011)

Circular RNA CpG island hypermethylation-associated silencing in human cancer
por: Ferreira, Humberto J., et al.
Publicado: (2018)

Urocortin and corticotropin-releasing factor receptor 2 in human renal cell carcinoma: disruption of an endogenous inhibitor of angiogenesis and proliferation
por: Tezval, Hossein, et al.
Publicado: (2009)

A reinvestigation of somatic hypermethylation at the PTEN CpG island in cancer cell lines
por: Hesson, Luke B, et al.
Publicado: (2012)

Detection of promoter hypermethylation of the CpG island of E-cadherin in gastric cardiac adenocarcinoma
por: Guo, W, et al.
Publicado: (2009)

Tissue of origin determines cancer-associated CpG island promoter hypermethylation patterns
por: Sproul, Duncan, et al.
Publicado: (2012)

CpG island hypermethylation-associated silencing of small nucleolar RNAs in human cancer
por: Ferreira, Humberto J., et al.
Publicado: (2012)

Effect of DNMT3A polymorphisms on CpG island hypermethylation in gastric mucosa
por: Takano, Hikaru, et al.
Publicado: (2020)

Enrichment of CpG island shore region hypermethylation in epigenetic breast field cancerization
por: Muse, Meghan E., et al.
Publicado: (2020)

The Role of H3K4 Trimethylation in CpG Islands Hypermethylation in Cancer
por: Zardo, Giuseppe
Publicado: (2021)

Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC)
por: Nicklas, André P., et al.
Publicado: (2018)

Discovery of Novel Hypermethylated Genes in Prostate Cancer Using Genomic CpG Island Microarrays
por: Kron, Ken, et al.
Publicado: (2009)

Hypermethylation of the DLC1 CpG island does not alter gene expression in canine lymphoma
por: Bryan, Jeffrey N, et al.
Publicado: (2009)

CpG island hypermethylation-associated silencing of microRNAs promotes human endometrial cancer
por: Li, Bi-Lan, et al.
Publicado: (2013)

Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylation
por: Brinkman, Arie B., et al.
Publicado: (2019)

Cancer Detection and Classification by CpG Island Hypermethylation Signatures in Plasma Cell-Free DNA
por: Huang, Jinyong, et al.
Publicado: (2021)

Surgical approach in patients with T4 bladder cancer as primary treatment: Disaster or option with improved quality of life
por: Nagele, Udo, et al.
Publicado: (2008)

Inactivation of O(6)-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers
por: Bae, S I, et al.
Publicado: (2002)

RASSF2, a potential tumour suppressor, is silenced by CpG island hypermethylation in gastric cancer
por: Endoh, M, et al.
Publicado: (2005)

A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines
por: Lind, Guro E, et al.
Publicado: (2004)

Hypermethylation of gene body CpG islands predicts high dosage of functional oncogenes in liver cancer
por: Arechederra, Maria, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_uccidmut135i040m2g03mhi3u3